Related Experiment Video
Updated: Jul 25, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.4K
ENT involvement in Leishmania infections.
Francisco Javier García Callejo1, Ramón Balaguer García1, Miguel Juantegui Azpilicueta1
1Servicio de Otorrinolaringología, Hospital de Requena, Requena, Valencia, España.
Acta Otorrinolaringologica Espanola
|May 14, 2020
Summary
Leishmaniasis, a parasitic disease transmitted by sandflies, commonly affects the head and neck in Spain, particularly in immunocompromised individuals. Early diagnosis and treatment are crucial for successful outcomes, with most patients achieving clinical and parasitological cure.
Area of Science:
- Medical Parasitology
- Infectious Diseases
- Dermatology
Background:
- Leishmaniasis is a group of diseases caused by Leishmania parasites, transmitted by sandflies from animal reservoirs.
- It presents in three main forms: cutaneous, mucocutaneous, and visceral (kala-azar).
- This study focuses on head and neck manifestations of leishmaniasis within a specific health area.
Purpose of the Study:
- To analyze the clinical, diagnostic, and therapeutic characteristics of leishmaniasis cases in the head and neck region.
- To determine the incidence and prevalence of leishmaniasis in the studied population.
- To highlight the importance of suspecting leishmaniasis in non-responsive cases and immunocompromised patients.
Main Methods:
- A 26-year retrospective review of leishmaniasis cases treated at a single hospital.
- Data collection included clinical presentation, diagnostic methods (primarily biopsy), treatment regimens, and patient outcomes.
- Epidemiological data such as age, immunodeficiency status, incidence, and prevalence were analyzed.
Main Results:
- Thirteen cases were identified: 7 cutaneous, 4 mucocutaneous, and 2 visceral.
- The mean age was 53.7 years, with 61% of cases occurring in immunocompromised individuals.
- Head and neck involvement, including the ear-nose-throat area, was present in 69% of patients. Diagnosis by biopsy was successful in 12 cases.
- Treatment with antimony compounds or amphotericin B resulted in a 92% clinical and parasitological cure rate.
Conclusions:
- Leishmaniasis in Spain frequently involves the head, face, neck, and upper airway mucosa.
- The clinical presentation is highly variable.
- Leishmaniasis should be suspected in cases with persistent lesions unresponsive to conventional treatment and in patients with immunodeficiency.
Related Concept Videos
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

